Document Detail


Double-blind, placebo-controlled trial on the effect of piracetam on breath-holding spells.
MedLine Citation:
PMID:  22302459     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Breath-holding spells (BHS) are apparently frightening events occurring in otherwise healthy children. The aim of this study was to evaluate the efficacy of piracetam in the treatment of breath-holding spells. Forty patients with BHS (who were classified into two groups) were involved in a double-blinded placebo-controlled prospective study. Piracetam was given to group A while group B received placebo. Patients were followed monthly for a total period of 4 months. The numbers of attacks/month before and monthly after treatment were documented, and the overall number of attacks/month after treatment was calculated in both groups. The median number of attacks/month before treatment in the two groups was 5.5 and 5, respectively, while after the first month of treatment, it was 2 and 5, respectively. The median overall number of attacks/month after treatment in both groups was 1 and 5, respectively. There was a significant decline of number of attacks after piracetam treatment compared to placebo (p value < 0.001). There were no reported side effects of the piracetam throughout the study period. In conclusion, piracetam is a safe and effective drug for the treatment of breath-holding spells in children.
Authors:
Happy Sawires; Osama Botrous
Related Documents :
22707339 - Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperati...
22433769 - Comparative effectiveness, cost, and utilization of radical prostatectomy among young m...
22323849 - Vestibular and stabilometric findings in whiplash injury and minor head trauma.
22744589 - Late results of surgical treated scoliosis with the use of selective and extend instrum...
22825889 - The relation between superior phacoemulsification incision and steep axis on astigmatic...
2896429 - Treatment of sex offenders with imaginal desensitization and/or medroxyprogesterone.
17101999 - Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related m...
21215579 - Role of recombinant factor viia in the treatment of intractable bleeding in vascular su...
20798439 - Five-year survival of nonagenerian patients undergoing total hip replacement in the uni...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-2-1
Journal Detail:
Title:  European journal of pediatrics     Volume:  -     ISSN:  1432-1076     ISO Abbreviation:  -     Publication Date:  2012 Feb 
Date Detail:
Created Date:  2012-2-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Pediatrics, Cairo University, Cairo, Egypt, happy7_kd@yahoo.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  RSV hospitalisation and healthcare utilisation in moderately prematurely born infants.
Next Document:  A 2-month-old infant with vomiting, seizures, and progressive apathy.